Evidence Library

Title: The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling.
Author: George A. K. van Voorn, Pepijn Vemer, Dominique Hamerlijnck, Isaac Corro Ramos, Geertruida J. Teunissen, Maiwenn Al, and Talitha L. Feenstra.
Date Published: 2016
Reference: Applied Health Economics and Health Policy. 14: 129–133.
Are service users or carers authors: No/Not Known

Abstract: New drugs or other new treatments are commonly assessed to see if they are cost-effective, based on the use of health economic models. As end users, patients are important stakeholders in these decisions but are rarely involved in developing the economic models. This article considers the possible benefits and risks of patient involvement in model development. Benefits of becoming involved would include a greater understanding and possible acceptance by patients of the models and better models informed by the patient expertise. The authors claim that the benefits may outweigh the risks and that patients should become involved.

External link: The following links will take you to information on this entry on an external website. INVOLVE is not responsible for the content or the reliability of the external websites. Click here

Related entry: none currently available

Categories: health
nature and extent of public involvement in research
journal article

Date Entered: 2019/03/04

Date Edited: 2019/03/04

Additional Info: